Induction of ErbB-3 Expression by α6β4 Integrin Contributes to Tamoxifen Resistance in ERβ1-Negative Breast Carcinomas

• Valentina Folgiero ,

  Contributed equally to this work with: Valentina Folgiero, Paolo Avetrani

  Affiliation Department of Experimental Oncology, Regina Elena Cancer Institute, Rome, Italy

  ⨯
• Paolo Avetrani ,

  Contributed equally to this work with: Valentina Folgiero, Paolo Avetrani

  Affiliation Department of Experimental Oncology, Regina Elena Cancer Institute, Rome, Italy

  ⨯
• Giulia Bon,

  Affiliation Department of Experimental Oncology, Regina Elena Cancer Institute, Rome, Italy

  ⨯
• Selene E. Di Carlo,

  Affiliation Department of Experimental Oncology, Regina Elena Cancer Institute, Rome, Italy

  ⨯
• Alessandra Fabi,

  Affiliation Department of Medical Oncology, Regina Elena Cancer Institute, Rome, Italy

  ⨯
• Cecilia Nisticò,

  Affiliation Department of Medical Oncology, Regina Elena Cancer Institute, Rome, Italy

  ⨯
• Patrizia Vici,

  Affiliation Department of Medical Oncology, Regina Elena Cancer Institute, Rome, Italy

  ⨯
• Elisa Melucci,

  Affiliation Department of Pathology, Regina Elena Cancer Institute, Rome, Italy

  ⨯
• Simonetta Buglioni,

  Affiliation Department of Pathology, Regina Elena Cancer Institute, Rome, Italy

  ⨯
• Letizia Perracchio,

  Affiliation Department of Pathology, Regina Elena Cancer Institute, Rome, Italy

  ⨯
• Isabella Sperduti,

  Affiliation Scientific Direction, Regina Elena Cancer Institute, Rome, Italy

  ⨯
• Laura Rosanò,

  Affiliation Department of Experimental Oncology, Regina Elena Cancer Institute, Rome, Italy

  ⨯
• Ada Sacchi,

  Affiliation Department of Experimental Oncology, Regina Elena Cancer Institute, Rome, Italy

  ⨯
• Marcella Mottolese,

  Affiliation Department of Pathology, Regina Elena Cancer Institute, Rome, Italy

  ⨯
• Rita Falcioni

  *E-mail: falcioni@ifo.it

  Affiliation Department of Experimental Oncology, Regina Elena Cancer Institute, Rome, Italy

  ⨯